212 related articles for article (PubMed ID: 2164347)
21. Immunohistochemical evaluation of P21ras and P53 proteins expression in human non-small-cell lung cancers.
Przybojewska B; Rydzynski K; Stepnik M; Jakubiak M; Kozak J; Szymczak W
Neoplasma; 2003; 50(3):198-203. PubMed ID: 12937853
[TBL] [Abstract][Full Text] [Related]
22. Expression pattern of the scaffold protein IQGAP1 in lung cancer.
Nakamura H; Fujita K; Nakagawa H; Kishi F; Takeuchi A; Aute I; Kato H
Oncol Rep; 2005 Mar; 13(3):427-31. PubMed ID: 15706411
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the pick-and-smear and Saccomanno methods for sputum cytologic analysis.
Rizzo T; Schumann GB; Riding JM
Acta Cytol; 1990; 34(6):875-80. PubMed ID: 2175137
[TBL] [Abstract][Full Text] [Related]
24. Role of metallothionein expression in non-small cell lung carcinomas.
Dziegiel P; Jeleń M; Muszczyńska B; Maciejczyk A; Szulc A; Podhorska-Okołów M; Cegielski M; Zabel M
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():43-5. PubMed ID: 15638370
[TBL] [Abstract][Full Text] [Related]
25. Cyclin A and Cyclin E expression in resected non-small cell lung cancer stage I-IIIA.
Kosacka M; Piesiak P; Porebska I; Korzeniewska A; Dyla T; Jankowska R
In Vivo; 2009; 23(4):519-25. PubMed ID: 19567385
[TBL] [Abstract][Full Text] [Related]
26. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT
Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942
[TBL] [Abstract][Full Text] [Related]
27. Proteomic signatures for histological types of lung cancer.
Seike M; Kondo T; Fujii K; Okano T; Yamada T; Matsuno Y; Gemma A; Kudoh S; Hirohashi S
Proteomics; 2005 Jul; 5(11):2939-48. PubMed ID: 15996008
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical analysis of tissue localization of cytokeratin 19 in lung cancer.
Chyczewski L; Nikliński J; Chyczewska E; Laudański J; Furman M
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():162-72. PubMed ID: 9337534
[TBL] [Abstract][Full Text] [Related]
29. The nuclear morphometry by image analysis in the histopathologic diagnosis of lung cancer.
Kavantzas N; Lazaris AC; Chatzigianni E; Davaris PS
J Exp Clin Cancer Res; 2000 Jun; 19(2):201-6. PubMed ID: 10965819
[TBL] [Abstract][Full Text] [Related]
30. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
[TBL] [Abstract][Full Text] [Related]
31. Fine needle aspiration cytology of atypical carcinoid of the lung.
Frierson HF; Covell JL; Mills SE
Acta Cytol; 1987; 31(4):471-5. PubMed ID: 3037832
[TBL] [Abstract][Full Text] [Related]
32. Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development.
Rusch V; Klimstra D; Linkov I; Dmitrovsky E
Cancer Res; 1995 Mar; 55(6):1365-72. PubMed ID: 7882337
[TBL] [Abstract][Full Text] [Related]
33. Expression of PTEN and FHIT is involved in regulating the balance between apoptosis and proliferation in lung carcinomas.
Zheng H; Tsuneyama K; Takahashi H; Miwa S; Nomoto K; Saito H; Masuda S; Takano Y
Anticancer Res; 2007; 27(1B):575-81. PubMed ID: 17348444
[TBL] [Abstract][Full Text] [Related]
34. Stainability of lung cancer cells with Leu-7 and OKT-9 monoclonal antibodies.
Sato Y; Watanabe S; Kodama T; Goto M; Shimosato Y
Jpn J Clin Oncol; 1985 Sep; 15(3):537-44. PubMed ID: 2414490
[TBL] [Abstract][Full Text] [Related]
35. Complex assessment of tumor cell proliferation in various forms of lung cancer.
Kazantseva IA; Machmudova GK
Acta Histochem Suppl; 1990; 39():155-62. PubMed ID: 1964232
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers.
Au NH; Cheang M; Huntsman DG; Yorida E; Coldman A; Elliott WM; Bebb G; Flint J; English J; Gilks CB; Grimes HL
J Pathol; 2004 Sep; 204(1):101-9. PubMed ID: 15307143
[TBL] [Abstract][Full Text] [Related]
37. Expression of the ras oncoprotein in gastric carcinomas and adjacent mucosa.
Karayiannis M; Yiagnisis M; Papadimitriou K; Spandidos DA
Anticancer Res; 1989; 9(6):1505-10. PubMed ID: 2697179
[TBL] [Abstract][Full Text] [Related]
38. Expression of 11 beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor in primary lung carcinomas.
Suzuki S; Suzuki T; Tsubochi H; Koike K; Tateno H; Krozowski ZS; Sasano H
Anticancer Res; 2000; 20(1A):323-8. PubMed ID: 10769675
[TBL] [Abstract][Full Text] [Related]
39. Expression of epithelial and neural antigens in small cell and non small cell lung carcinoma.
Moss F; Bobrow LG; Sheppard MN; Griffiths M; Rowe D; Beverley PC; Addis B; Souhami RL
J Pathol; 1986 Jun; 149(2):103-11. PubMed ID: 2426429
[TBL] [Abstract][Full Text] [Related]
40. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers.
Wu M; Szporn AH; Zhang D; Wasserman P; Gan L; Miller L; Burstein DE
Diagn Cytopathol; 2005 Oct; 33(4):223-7. PubMed ID: 16138374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
